| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 02/22/2007 | WO2006134163A8 Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain |
| 02/22/2007 | WO2006130160A3 Furanopyridine derivatives as ack1 and lck modulators |
| 02/22/2007 | WO2006128852A3 Heterocyclic spiro-compounds as aldosterone synthase inhibitors |
| 02/22/2007 | WO2005058910B1 The method of manufacturing of 7-ethyl-10-hydroxycamptothecin |
| 02/22/2007 | US20070043225 Method for the production of 3-amino-5-(hydroxymethyl) cyclopentane-1,2-diol-derivatives |
| 02/22/2007 | US20070043067 7-Polyaminoalkyl(oxy)iminomethylcamptothecins bearing protective groups |
| 02/22/2007 | US20070043060 Inflammations of the respiratory system, locomotor system traumas, and edemas; 1-{[5-(4-Chlorophenyl)-4-(2,4-dichlorophenyl)-1,3-oxazol-2-yl]carbonyl}-4-(3-methylphenyl)piperazine |
| 02/22/2007 | US20070043039 Tumor suppression agents with reduced side effects; anticancer; antibacterial and antiviral |
| 02/22/2007 | US20070043008 Condensed Bicyclo[3.1.0] Hex-4-EN Derivatives Useful as Antibacterial Agents |
| 02/22/2007 | US20070042968 Sulfur compounds as inhibitors of Hepatitis C virus NS3 serine protease |
| 02/22/2007 | CA2619276A1 Pentacyclic kinase inhibitors |
| 02/22/2007 | CA2617953A1 Method of acylating maytansinol with chiral amino acids |
| 02/21/2007 | EP1754707A2 Multicyclic compounds and their use as inhibitors of PARP, VEGFR2 and MLK3 enzymes |
| 02/21/2007 | EP1754706A1 SELECTIVE INHIBITORS AGAINST Cdk4 AND Cdk6 HAVING AMINOTHIAZOLE SKELETON |
| 02/21/2007 | EP1753463A2 Antibody drug conjugates and methods |
| 02/21/2007 | EP1753428A2 Kinase inhibitors as therapeutic agents |
| 02/21/2007 | EP1753397A2 Galantamine salts, method of producing it and nasal composition thereof |
| 02/21/2007 | EP1551797B1 Cyclohexyl sulphone derivatives as gamma-secretase inhibitors |
| 02/21/2007 | EP1355905B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/21/2007 | EP0968193B1 Phenylsulphonyl ureas, processes for their preparation and their use as herbicides and plant-growth regulators |
| 02/21/2007 | CN1918172A 利福霉素类似物及其用途 Rifamycin analogs and their use |
| 02/21/2007 | CN1918170A 7-polyaminoalkyl(oxy)iminomethylcamptothecins bearing protective groups |
| 02/21/2007 | CN1918169A Cysteine protease inhibitors |
| 02/21/2007 | CN1918160A Novel tricyclic spiroderivatives as modulators of chemokine receptor activity |
| 02/21/2007 | CN1918153A Oxazole derivatives, preparation and therapeutic use thereof |
| 02/21/2007 | CN1918147A 1,2,3,4-tetrahydroisoquinoline derivatives, preparations thereof and uses thereof |
| 02/21/2007 | CN1917921A Calcitonin gene related peptide receptor antagonists |
| 02/21/2007 | CN1916760A Acid-producing agent, sulfonic acid, sulfonic acid derivative and radiation-sensitive resin composition |
| 02/21/2007 | CN1915995A S type 4-substituted hydroxy-pyranindolelidinyl compounds and its derivatives and production method |
| 02/20/2007 | US7179834 Fermentation product of marine actinomyces strains ; antiproligferative agents; anticancer agents |
| 02/20/2007 | US7179819 Benzyl -urea, -thiourea, or -guanidine derivatives that inhibit the binding of ligands to alpha 4 beta 1 integrin (VLA-4); for therapy and prophylaxis of pathologies associated with VLA-4 mediated cell adhesion, such as inflammatory and autoimmune diseases, and tumor metastasis |
| 02/20/2007 | US7179815 For example, 3-[2(R)-{hydroxycarbonylpropyl-amino}-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methyl-pyrimidine-2,4(1H,3H)-dione; use in treating prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis |
| 02/20/2007 | US7179806 Δ1-pyrrolines used as pesticides |
| 02/20/2007 | CA2325776C Novel analogue compounds of camptothecin, process for preparing them and pharmaceutical compositions containing them |
| 02/15/2007 | WO2007018168A1 Acylguanidine derivative or salt thereof |
| 02/15/2007 | WO2007017584A1 Novel camptothecin analogues compounds, a method for the preparation thereof and pharmaceutical compositions containing said compounds |
| 02/15/2007 | WO2007017083A1 Pyrazole derivatives having tyrosinkinase activity |
| 02/15/2007 | WO2007017078A1 NEW PYRIDO[3',2':4,5]FURO[3,2-d]PYRIMIDINE DERIVATIVES |
| 02/15/2007 | WO2007016979A2 NOVEL HETEROCYCLIC NF-κB INHIBITORS |
| 02/15/2007 | WO2005092897A3 2,4,6-phenylsubstituted cyclic ketoenoles |
| 02/15/2007 | US20070037972 For making maytansinoids with chiral amino acid side chains; maytansinoids may be conjugated to cell-binding agents such as antibodies and are useful therapeutics, especially for treatment of cancer; high yielding methods that avoid or reduce epimerization in coupling of side chain linker |
| 02/15/2007 | US20070037840 Tricyclic benzimidazoles |
| 02/15/2007 | US20070037838 Substance which exhibits antiviral and antibacterial activity and is based on derivatives of 2,8-dithioxo-1h-pyrano[2,3d 6,5-d']dipyrimidyne and 10-aza-analogue thereof |
| 02/15/2007 | US20070037810 Sirtuin modulating compounds |
| 02/15/2007 | US20070037805 Fused heteroaryl derivatives |
| 02/15/2007 | CA2618524A1 Pyrazole derivatives having tyrosine kinase activity |
| 02/15/2007 | CA2617951A1 Novel camptothecin analogues compounds, a method for the preparation thereof and pharmaceutical compositions containing said compounds |
| 02/15/2007 | CA2617473A1 Acylguanidine derivative or salt thereof |
| 02/15/2007 | CA2617225A1 Novel heterocyclic nf-kb inhibitors |
| 02/15/2007 | CA2616424A1 New pyrido[3',2':4,5]furo[3,2-d]pyrimidine derivatives |
| 02/14/2007 | EP1752455A2 Chemokine receptor binding heterocyclic compounds |
| 02/14/2007 | EP1751286A2 Biosynthetic gene cluster for the production of a complex polyketide |
| 02/14/2007 | EP1751168A1 Proline cci-779 (proline-rapamycin 42-ester with 2,2-bis (hydroxymethyl) propionic acid) and two-step enzymatic synthesis of proline cci-779 and cci-779 using microbial lipase |
| 02/14/2007 | EP1751165A1 4-substituted 1,5-dihydro-pyrido(3,2-b)indol-2-ones |
| 02/14/2007 | EP1751157A1 Inhibitors of the hiv integrase enzyme |
| 02/14/2007 | EP1751130A2 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands |
| 02/14/2007 | EP1751129A1 Method for producing 1,3-dioxolan-4,6-dione compound |
| 02/14/2007 | EP1751108A1 Adamantyl-acetamide derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 02/14/2007 | EP1750706A1 Dual small molecule inhibitors of cancer and angiogenesis |
| 02/14/2007 | EP1562944B1 Pyrazoloquinolines with immunomodulating activity |
| 02/14/2007 | EP1392355B1 Use of proteasome inhibitors to treat dry eye disorders |
| 02/14/2007 | EP1345928B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/14/2007 | EP1017676B1 Method for the synthesis of quinoline derivatives |
| 02/14/2007 | EP0820283B1 Lactacystin analogs |
| 02/14/2007 | CN1914509A Time-temperature indicator based on valence isomerizations |
| 02/14/2007 | CN1914211A Preventive or therapeutic agent for diabetic maculopathy |
| 02/14/2007 | CN1914207A Azepinoindole derivatives as pharmaceutical agents |
| 02/14/2007 | CN1914172A 2-ethyl-4,6-dimethyl-phenyl-substituted spirocyclic tetramic acid derivatives |
| 02/14/2007 | CN1913897A Novel compound, corresponding compositions, preparation and/or treatment methods |
| 02/14/2007 | CN1911933A Oxygen, nitrogen heterocyclic naphthoyl imine kind compound and its bioapplication |
| 02/14/2007 | CN1911932A Method for separating preparing tripterygium wilfordii monomer from tripterygium wilfordii by countercurrent flow chromatography |
| 02/14/2007 | CN1911931A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 02/14/2007 | CN1911930A Chemokine receptor anagonists, methods and use therefor |
| 02/14/2007 | CN1911915A Lactam compound and medicinal use thereof |
| 02/14/2007 | CN1300112C Synthesis method of N-benzyl-4-piperidyl formaldehgde |
| 02/14/2007 | CN1300110C Hydroxamate derives useful as deacetylase inhibitors |
| 02/14/2007 | CN1299677C 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 02/13/2007 | US7176322 Bone disorders; hyperparathyroidism; such as N-((1-ethyl-3-phenyl-1H-indol-5-yl)methyl)-1-phenylethanamine |
| 02/13/2007 | US7176235 10,11-Dehydroepothilones; anticancer, antiproliferative and antiarthritic agents |
| 02/13/2007 | US7176233 Salinosporamides and methods for use thereof |
| 02/13/2007 | US7176232 Fermentation product of marine actinomyces strains; antiproliferative agents; anticancer agents |
| 02/13/2007 | US7176215 Bicyclic oxopyridine and oxopyrimidine derivatives |
| 02/13/2007 | US7176214 Imidazo-fused oxazolo[4,5-β]pyridine and imidazo-fused thiazolo[4,5-β]pyridine based tricyclic compounds and pharmaceutical compositions comprising same |
| 02/13/2007 | US7176213 For example, 1-(9-benzylamino-10-cyano-imidazo[1,2-a]quinolin-2-carbonyl)pyrrolidine; may be used for the treatment of diseases such as asthma, glaucoma, tumors, allergic and inflammatory diseases, ischemia, hypoxia, arrythmia and renal diseases |
| 02/13/2007 | US7176196 Bicyclic heterocycles as HIV integrase inhibitors |
| 02/13/2007 | US7176161 Containing crystalline compounds which produce color when thermally converted to liquid or amorphous form time-independent |
| 02/13/2007 | CA2387198C Method for treating hair loss using thyromimetic compounds |
| 02/08/2007 | WO2007016525A2 Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices |
| 02/08/2007 | WO2005084315A3 Pyranoindole derivatives and the use thereof for the treatment of hepatitis c virus infection or disease |
| 02/08/2007 | US20070032653 N-{1-(4-(3-bromophenyl)-1H-imidazol-2-yl)-5-methylhexyl}-N-cyclohexylamine; agonists or antagonists of somatostatin receptors; acromegaly, restenosis, Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites, nesidoblastosis, hyperinsulinism, gastrinoma, etc. |
| 02/08/2007 | US20070032652 contacting a picolinic acid derivative with a benzothiazole derivative or tautomers thereof, in the presence of a non-nucleophilic base; compounds inhibit cell proliferation, induce cell apoptosis and stabilize a quadruplex structure |
| 02/08/2007 | US20070032640 Cytokine receptor |
| 02/08/2007 | US20070032518 Compounds and methods of use |
| 02/08/2007 | US20070032469 Tricyclic benzimidazoles and their use as metabotropic glutamate receptor modulators |
| 02/08/2007 | US20070031336 3H-phenoxazine derivatives suitable as near-infrared imaging agents, preparation an use thereof |
| 02/08/2007 | CA2617213A1 Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices |
| 02/07/2007 | EP1749817A1 Neurogenic pain control agent composition |
| 02/07/2007 | EP1749011A1 Bicyclic heterocycles as hiv integrase inhibitors |
| 02/07/2007 | EP1748980A1 Pyrrolidine derivatives as cb1-receptor antagonists |
| 02/07/2007 | EP1397366B1 Novel ligand for nicotinic acetylcholine receptors useful in therapy |